The test laboratory for vine-growing in the town of Septemvri uses the waste from the production of Biovet - Peshtera as a fertilizer for rooting. Biovet is a candidate for author certificate before the Patent administration. The pharmaceutical company financed the project with BGN 5000.
Source: Maritsa (13.02.2000)

Bulgarian Pharmaceutical Company JSC - Sofia was selected a buyer of 54 per cent of Biovet JSC - Peshtera. There were two offers for the company's major stake - the one of Bulgarian Pharmaceutical Company JSC and one submitted by Italian company Sintopharm.
Source: Sega (01.03.2000)

Bulgarian Pharmaceutical Company JSC offered USD 11 million for 54 per cent of Biovet JSC - Peshtera and was selected a buyer by PA. The buyer must pay up to March 17th as well as make investments of USD 10 million in the next 5 years.
Source: Standart (02.03.2000)

8 companies will be included in PA's cash privatization list. These are BTC SPJSC, Bulgartabac Holding JSC, Chernomorski Solnitzi SPJSC, Energoremont - Galabovo JSC, Biovet - Peshtera JSC, Energoremont - Sofia JSC, Geosol SPJSC - Provadia, Zavod za Dobiv na Varovik SPJSC. In 1999 were privatized long-term tangible assets of BGN 84 million.
Source: Trud (17.03.2000)

On March 14th, 2000 PA signed a contract with the potential buyer of Biovet JSC - Peshtera - Bulgarian pharmaceutical Company JSC. So far the deal has not been approved by PA's Supervisory Board.
Source: Pari (04.04.2000)

The Deputy Prime Minister Mr. Peter Zhotev has to take Zlatni Piasatzi deal in the Supervisory Board of the agency or it may be contested, stated its Director Mr. Assen Dulgerov. Zhotev began negotiations for the resort with the chosen for the buyer MEBO Zlatni that is in consortium with Neckerman and Agreda.
Source: Standart (13.04.2000)

The Supervisory Board of the PA approved the purchase of 54 per cent of Biovet JSC - Peshtera of Bulgarian pharmaceutical company JSC for USD 10 639 000. The contract will be signed next week, reported the Chairman of the Supervisory Board Mr. Assen Dulgerov. 30 per cent of the price has to be paid cash in the day of the sign of the agreement and the rest 70 per cent in a period of 45 days. The buyer has an obligation to invest for 5 years USD 10 030 000. For the same period the work-places must be kept. For the purchase BPC receives a credit of USD 9 700 000 from Bulbank JSC. As a guarantee the main shareholder in BPC - Napreduk Holding pledged its shares that possesses from the mass privatization in Biovet (5 - 6 per cent).
Source: BTA (20.04.2000)

Biovet is one of the profitable Bulgarian companies - it does not have debts, exports the bigger part of the production, ends every year with a profit. The buyer of the company, Bulgarian pharmaceutical company JSC, is registered in the end of the last year. Its major owner is the former privatization fund Napredak holding and the rest 19 per cent of the capital are property of Mr. Petko Neijkov.
Source: Capital (21.04.2000)

The buyer of Biovet JSC - Peshtera, - Bulgarian Pharmaceutical Company paid the whole amount of USD 10.639 million in cash on the day of the sign of the contract.
Source: 24 chasa (26.04.2000)

The Board of Directors of Biovet JSC - Peshtera convenes a General Meeting of the Shareholders on June 9 2000.
Source: State Gazette (05.05.2000)

PA announced that the following deals were signed in April 2000: I. main sales: Biovet JSC - Peshtera: 54 per cent of the capital were sold to Bulgarian Pharmaceutical Company JSC for USD 10 639 000.
Source: State Gazette (30.05.2000)

The General Meeting of Biovet JSC decided to turn in a two-tier form of management. Mr. Kiril Domusschiev is the Chairman of the Supervisory Board and Mr. Ivan Batakliev - the Executive Director of the Board of Directors. There were voted changes in the statute of the company as the bigger part of the decisions will be taken with 51 per cent of the capital, not with 67 per cent as has been so far. It was decided not to be paid a dividend and the whole profit in amount of BGN 7 million to be used for capitalization of the company.
Source: Banker (13.06.2000)

Pazardzhik District Court entered in the trade register a change concerning Biovet JSC - Peshtera: enters as procurator of the company Mr. Angel Zheliazkov Ivanov, who will represent the company and will manage it together with the Executive Director Mr. Ivan Petrov Batakliev.
Source: State Gazette (16.06.2000)

Pazardzhik District Court entered in the trade register the following changes concerning Boivet JSC - Peshtera: erases the current Board of Directors; enters a two-level system of management with a Supervisory Board with the following members: Mr. Kiril Petrov Domuschiev, Me. Petko Vasilev Neikov and Mr. Daniel Georgiev Apostolov and a Board of Directors with the following members: Mr. Bozhidar Vasilev Keremidchiev, Mr. Angel Kirilov Gekov, Mrs. Temenuga Ivanova Gazdova, Mr. Angel Zheliazkov Ivanov, Mr. Ivan Petrov Batakliev and Mr. Bozhidar Spasov Petkov; the company is managed and represented by the executive directors Mr. Ivan Petrov Batakliev and Mr. Angel Zhelizkov Ivanov together.
Source: State Gazette (18.07.2000)

The Board of Directors of Biovet JSC - Peshtera convenes a General Meeting of the Shareholders on September 8 2000.
Source: State Gazette (21.07.2000)

Pazardzhik District Court entered in the trade register a change concerning Boivet JSC - Peshtera; the company's subject of activity is: production and trade with veterinary-medical products, agricultural and medical products, as well as trade and services - hotel, restaurant, tourest and agent activity in the country and abroad, transport activity and any other activity allowed by the law.
Source: State Gazette (04.08.2000)

MPs from Shoumen region took funds from the Turkish company Pafmetal for Alumina-Shoumen, declared Mr. Vladimir Karolev at a discussion. According to Mr. Karolev the Director of PA Mr. Zahari Zheliazkov sold the resort Elenite to his friends and Biovet to Domuschievi Brothers instead of the Italian company Sintofarm. According to the participants in the discussion the privatization in the State is not effective. For the last 2 years Bulgaria expected to receive USD 4 billion but not more than USD 1 billion were the incomes from the privatization.
Source: Trud (03.11.2000)

PA prolonged by December 20 the deadline for submitting the offers for sale of 51 per cent from the capital of Intertravelservice JSC - Sofia. Totally 6 companies bought information memoranda for participation in the auction, was specified from PA. These are Balkantourist JSC, Dimex Corporation JSC, Biovet JSC, Trade centre JSC, Roumiana Stoycheva SP and Transstroy-M SP Ltd. The company will be privatized through negotiations with a potential buyer. The decision for privatization of the company was opened by PA on October 12, 1998. The activity of Intertravelservices JSC, Sofia is hotel and restaurant keeping, transport services and international tourism. Its capital is 310 624 000 non-denominated levs. 25 per cent from the company are privatized through the mass privatization.
Source: Sega (28.11.2000)